A Phase II Study Of Preoperative Celecoxib/Paclitaxel/Carboplatin For Squamous Cell And Adenocarcinoma Of The Esophagus
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Carboplatin; Celecoxib; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 17 Dec 2009 Pfizer added as trial sponsor as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.